©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Contributor:

Pravin U. Dugel, MD

Angiogenesis 2021: Geographic Atrophy

Beyond the Walls of ORs and Borders of Nations

Pravin Dugel, MD, Visits Nepal After Earthquake
Pravin Dugel, MD, Visits Nepal After Earthquake

Pravin Dugel, MD, Shares a Family's Story in Nepal After an Earthquake
Pravin Dugel, MD, Shares a Family's Story in Nepal After an Earthquake

OCTA for a Case of Neovascular AMD
OCTA for a Case of Neovascular AMD

Pravin Dugel, MD

Abicipar Pegol in Phase 2
Abicipar Pegol in Phase 2

Pravin Dugel, MD

Head-to-Head Trials
Head-to-Head Trials

Pravin Dugel, MD

Will Informatics Make Better Surgeons?
Will Informatics Make Better Surgeons?

Pravin Dugel, MD, R. Ross Lakhanpal, MD

Predicting Response to Anti-VEGF Monotherapy
Predicting Response to Anti-VEGF Monotherapy

Pravin Dugel, MD, Timothy Murray, MD, MBA

OCT-A Findings in Relation to VA
OCT-A Findings in Relation to VA

Pravin Dugel, MD

Subretinal Infusion
Subretinal Infusion

Pravin Dugel, MD

Proportional Reflux Dissection
Proportional Reflux Dissection

Pravin Dugel, MD

PVR and Subretinal PFO
PVR and Subretinal PFO

Pravin Dugel, MD

OCT-A: Implications for Detection of CNV Prior to Recurrence
OCT-A: Implications for Detection of CNV Prior to Recurrence

Pravin Dugel, MD

CNV Visualization on OCT-A May Inform Treat-and-Extend Decisions
CNV Visualization on OCT-A May Inform Treat-and-Extend Decisions

Pravin Dugel, MD

Phase 1 Results for a Novel Anti-VEGF/Anti-ANG2 Antibody
Phase 1 Results for a Novel Anti-VEGF/Anti-ANG2 Antibody

Pravin Dugel, MD

Results of ESBA 1008, a Single-Chain Antibody Fragment, for the Treatment of Neovascular AMD
Results of ESBA 1008, a Single-Chain Antibody Fragment, for the Treatment of Neovascular AMD

Pravin Dugel, MD

Promising Drugs in Pipeline Debut at Euretina
Promising Drugs in Pipeline Debut at Euretina

Pravin Dugel, MD

Current Treatment Approaches
Current Treatment Approaches

Pravin U. Dugel MD

Vitreomacular Adhesion with DME
Vitreomacular Adhesion with DME

Pravin U. Dugel MD

Three Exciting New Drugs
Three Exciting New Drugs

Pravin U. Dugel, MD